Karl and Erum sit down with Erika Milczek, CEO and founder of Curie Co, to explore how synthetic biology is rewriting the rules of modern chemistry. Erika, a former Merck chemist, shares her journey from Big Pharma to launching a biotech startup that engineers enzymes to replace legacy chemicals in personal care and consumer goods. With insights grounded in regulatory shifts, manufacturing scalability, and the power of directed evolution, Erika discusses how her team is building a “biotech alternative to petroleum-based chemistry.” Whether you're curious about enzyme engineering, bioindustrial startups, or how synthetic biology can drive sustainability in everyday products, this episode delivers a high-energy, deeply technical, and inspiring dive into the future of materials innovation.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters:00:00:00 - Welcome to the Future: Setting the Stage00:00:22 - Juggling Labs, Life, and Launchpads00:01:27 - Terraforming Mars? Let’s Dream Big00:04:58 - Joe Rogan, Speciation, and Sci-Fi Tangents00:10:08 - Biotech Beauty Week: Innovation on Display00:14:13 - Meet Erika Milczek: Enzymes Over Everything00:33:03 - Feeding the Bug: The Spark Behind Discovery00:35:15 - Scaling Science: What Makes Commercialization Hard00:35:51 - Why Partnerships Make or Break Biotech00:38:02 - Following the Rules: Regulatory Shifts & Product Strategy00:42:48 - From the Lab to RTP: Building in Biotech's Backyard00:45:37 - Ecosystem First: How to Build Bio Economies00:50:01 - Fundraising Real Talk: Investors, Guts & Growth00:53:50 - Biomanufacturing Is Just Getting Started00:56:29 - Let’s Talk Packaging: Biotech’s Next Frontier00:59:52 - Wrapping Up: Lessons, Hope, and What’s NextLinks and Resources:Curie CoMars: One Day on the Red Planet (film)Marsbound by Joe Haldeman (book) The case for Mars terraforming research (Erika de Benedicts research paper)Ben Lamm on Joe Rogan ExperienceDire Wolf on the cover to Time MagazineSupplier's Day 2025 during Messaginglab's unofficial Biotech Beauty WeekCapsum - microfluidics contract manufacturingP2 company - conditioning agents⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Topics Covered: biomanufacturing, cell free biomanufacturing, enzymes, nutraceuticals, biotech, pharmaceuticals, AI, spinoutsHave a question or comment? Message us here:Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email: [email protected] by: NihiloreProduction by: Amplafy Media

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related